Pharma companies are discovering that developing apps and digital health technologies is just like developing drugs--at least when it comes to persuading payers to cover them.
Crystal Lake, Illinois-based Aptar Pharma launched technology designed to monitor dosing and adherence in its inhalers. It also teamed up with Adapt Pharma to provide a nasal spray device to reverse opioid overdose, also using metered dosing technology.